Literature DB >> 4063877

Impact of the recording bandwidth on the electroretinogram.

P Lachapelle.   

Abstract

Previous investigators have suggested using a recording bandwidth of 100 to 1000 Hz to selectively amplify the oscillatory potentials (OPs) of the electroretinogram (ERG). The data reported in this article do not support this recommendation. Comparisons between the usual broadband (1- to 1000-Hz) ERG and that recorded with a narrower bandwidth (100 to 1000 Hz) indicate that the two ERGs have the same temporal features. The only differences noted are in amplitude and configuration, and these filter-induced modifications are predictable. The 100- to 1000-Hz ERG thus appears more like a low-voltage version of the 1- to 1000-Hz one than a recording with selective amplification of some hidden high-frequency subcomponents. A novel interpretation of ERG-wave synthesis that could account for these findings is suggested.

Mesh:

Year:  1985        PMID: 4063877

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  5 in total

1.  Oscillatory potentials as predictors to amplitude and peak time of the photopic b-wave of the human electroretinogram.

Authors:  P Lachapelle
Journal:  Doc Ophthalmol       Date:  1990-08       Impact factor: 2.379

2.  ERG oscillatory potentials in infants.

Authors:  Anne Moskowitz; Ronald M Hansen; Anne B Fulton
Journal:  Doc Ophthalmol       Date:  2005 Mar-May       Impact factor: 2.379

3.  The effect of iodoacetic acid on the electroretinogram and oscillatory potentials in rabbits.

Authors:  P Lachapelle; J Benoit; P Guité; C N Tran; S Molotchnikoff
Journal:  Doc Ophthalmol       Date:  1990-08       Impact factor: 2.379

4.  Maturation of the electroretinogram of the neonatal rabbit.

Authors:  J Gorfinkel; P Lachapelle; S Molotchnikoff
Journal:  Doc Ophthalmol       Date:  1988-07       Impact factor: 2.379

Review 5.  The Value of Imaging and Composition-Based Biomarkers in Duchenne Muscular Dystrophy Clinical Trials.

Authors:  Stephen M Chrzanowski; Basil T Darras; Seward B Rutkove
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.